Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making

A. Aziz, SF. Shariat, F. Roghmann, S. Brookman-May, CG. Stief, M. Rink, FK. Chun, M. Fisch, V. Novotny, M. Froehner, MP. Wirth, MJ. Schnabel, HM. Fritsche, M. Burger, A. Pycha, A. Brisuda, M. Babjuk, S. Vallo, A. Haferkamp, J. Roigas, J. Noldus,...

. 2016 ; 117 (2) : 272-9. [pub] 20150524

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc16021035

OBJECTIVE: To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) proposed by May et al. (Urol Oncol 2013; 31: 1141-1147) and to develop a new pT4a-specific nomogram predicting CSS in an international multicentre cohort of patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB) PATIENTS AND METHODS: Data from 856 patients with pT4a UCB treated with RC at 21 centres in Europe and North-America were assessed. The risk model proposed by May et al., which includes female gender, presence of positive lymphovascular invasion (LVI) and lack of adjuvant chemotherapy administration as adverse predictors for CSS, was applied to our cohort. For the purpose of external validation, model discrimination was measured using the receiver-operating characteristic-derived area under the curve. A nomogram for predicting CSS in pT4a UCB after RC was developed after internal validation based on multivariable Cox proportional hazards regression analysis evaluating the impact of clinicopathological variables on CSS. Decision-curve analyses were applied to determine the net benefit derived from the two models. RESULTS: The estimated 5-year-CSS after RC was 34% in our cohort. The risk model devised by May et al. predicted individual 5-year-CSS with an accuracy of 60.1%. In multivariable Cox proportional hazards regression analysis, female gender (hazard ratio [HR] 1.45), LVI (HR 1.37), lymph node metastases (HR 2.54), positive soft tissue surgical margins (HR 1.39), neoadjuvant (HR 2.24) and lack of adjuvant chemotherapy (HR 1.67, all P < 0.05) were independent predictors of an adverse CSS rate and formed the features of our nomogram with a predictive accuracy of 67.1%. Decision-curve analyses showed higher net benefits for the use of the newly developed nomogram in our cohort over all thresholds. CONCLUSIONS: The risk model devised by May et al. was validated with moderate discrimination and was outperformed by our newly developed pT4a-specific nomogram in the present study population. Our nomogram might be particularly suitable for postoperative patient counselling in the heterogeneous cohort of patients with pT4a UCB.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16021035
003      
CZ-PrNML
005      
20220720101815.0
007      
ta
008      
160722s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bju.12984 $2 doi
024    7_
$a 10.1111/bju.12984 $2 doi
035    __
$a (PubMed)25381844
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Aziz, Atiqullah $u Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. $7 gn_A_00010718
245    10
$a Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making / $c A. Aziz, SF. Shariat, F. Roghmann, S. Brookman-May, CG. Stief, M. Rink, FK. Chun, M. Fisch, V. Novotny, M. Froehner, MP. Wirth, MJ. Schnabel, HM. Fritsche, M. Burger, A. Pycha, A. Brisuda, M. Babjuk, S. Vallo, A. Haferkamp, J. Roigas, J. Noldus, R. Stredele, B. Volkmer, PJ. Bastian, E. Xylinas, M. May,
520    9_
$a OBJECTIVE: To externally validate the pT4a-specific risk model for cancer-specific survival (CSS) proposed by May et al. (Urol Oncol 2013; 31: 1141-1147) and to develop a new pT4a-specific nomogram predicting CSS in an international multicentre cohort of patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB) PATIENTS AND METHODS: Data from 856 patients with pT4a UCB treated with RC at 21 centres in Europe and North-America were assessed. The risk model proposed by May et al., which includes female gender, presence of positive lymphovascular invasion (LVI) and lack of adjuvant chemotherapy administration as adverse predictors for CSS, was applied to our cohort. For the purpose of external validation, model discrimination was measured using the receiver-operating characteristic-derived area under the curve. A nomogram for predicting CSS in pT4a UCB after RC was developed after internal validation based on multivariable Cox proportional hazards regression analysis evaluating the impact of clinicopathological variables on CSS. Decision-curve analyses were applied to determine the net benefit derived from the two models. RESULTS: The estimated 5-year-CSS after RC was 34% in our cohort. The risk model devised by May et al. predicted individual 5-year-CSS with an accuracy of 60.1%. In multivariable Cox proportional hazards regression analysis, female gender (hazard ratio [HR] 1.45), LVI (HR 1.37), lymph node metastases (HR 2.54), positive soft tissue surgical margins (HR 1.39), neoadjuvant (HR 2.24) and lack of adjuvant chemotherapy (HR 1.67, all P < 0.05) were independent predictors of an adverse CSS rate and formed the features of our nomogram with a predictive accuracy of 67.1%. Decision-curve analyses showed higher net benefits for the use of the newly developed nomogram in our cohort over all thresholds. CONCLUSIONS: The risk model devised by May et al. was validated with moderate discrimination and was outperformed by our newly developed pT4a-specific nomogram in the present study population. Our nomogram might be particularly suitable for postoperative patient counselling in the heterogeneous cohort of patients with pT4a UCB.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a karcinom z přechodných buněk $x mortalita $x patologie $x chirurgie $7 D002295
650    _2
$a adjuvantní chemoterapie $7 D017024
650    _2
$a klinické rozhodování $7 D000066491
650    _2
$a cystektomie $x metody $x mortalita $7 D015653
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a nomogramy $7 D049451
650    _2
$a hodnocení výsledků zdravotní péče $7 D017063
650    _2
$a prognóza $7 D011379
650    _2
$a proporcionální rizikové modely $7 D016016
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nádory močového měchýře $x mortalita $x patologie $x chirurgie $7 D001749
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a Severní Amerika $x epidemiologie $7 D009656
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a validační studie $7 D023361
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University Vienna, Vienna, Austria.
700    1_
$a Roghmann, Florian $u Department of Urology, Marienhospital Herne, Ruhr-University Bochum, Herne, Germany.
700    1_
$a Brookman-May, Sabine $u Department of Urology, Ludwig-Maximilians-University Munich, Munich, Germany.
700    1_
$a Stief, Christian G $u Department of Urology, Ludwig-Maximilians-University Munich, Munich, Germany.
700    1_
$a Rink, Michael $u Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Chun, Felix K $u Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Fisch, Margit $u Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Novotny, Vladimir $u Department of Urology, University Hospital 'Carl Gustav Carus', Dresden Technical University, Dresden, Germany.
700    1_
$a Froehner, Michael $u Department of Urology, University Hospital 'Carl Gustav Carus', Dresden Technical University, Dresden, Germany.
700    1_
$a Wirth, Manfred, $u Department of Urology, University Hospital 'Carl Gustav Carus', Dresden Technical University, Dresden, Germany. $d 1949- $7 xx0012316
700    1_
$a Schnabel, Marco J $u Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
700    1_
$a Fritsche, Hans-Martin $u Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
700    1_
$a Burger, Maximilian $u Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
700    1_
$a Pycha, Armin $u Department of Urology, General Hospital of Bolzano, Bolzano, Italy.
700    1_
$a Brisuda, Antonin $u Department of Urology, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Babjuk, Marko $u Department of Urology, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Vallo, Stefan $u Department of Urology, Goethe-University Frankfurt, Frankfurt am Main, Germany.
700    1_
$a Haferkamp, Axel $u Department of Urology, Goethe-University Frankfurt, Frankfurt am Main, Germany.
700    1_
$a Roigas, Jan $u Department of Urology, Vivantes Medical Centre im Friedrichshain and am Urban, Berlin, Germany.
700    1_
$a Noldus, Joachim $u Department of Urology, Marienhospital Herne, Ruhr-University Bochum, Herne, Germany.
700    1_
$a Stredele, Regina $u Department of Urology, Kassel Medical Centre, Kassel, Germany.
700    1_
$a Volkmer, Björn $u Department of Urology, Kassel Medical Centre, Kassel, Germany.
700    1_
$a Bastian, Patrick J $u Department of Urology, Paracelsus Medical Centre Golzheim, Düsseldorf, Germany.
700    1_
$a Xylinas, Evanguelos $u Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.
700    1_
$a May, Matthias $u Department of Urology, St. Elisabeth Medical Centre Straubing, Straubing, Germany.
773    0_
$w MED00011371 $t BJU international $x 1464-410X $g Roč. 117, č. 2 (2016), s. 272-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25381844 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20220720101811 $b ABA008
999    __
$a ok $b bmc $g 1155705 $s 945563
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 117 $c 2 $d 272-9 $e 20150524 $i 1464-410X $m BJU international $n BJU Int $x MED00011371
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Možnosti archivace